Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
China Bio-Immunity Corporation Reports Third Quarter 2008 Financial Results
December 3rd, 2008
China Bio-Immunity Corporation (BULLETIN BOARD: CHHB) (China Bio-Immunity" or "the Company"), a China-based company that develops, produces, manufactures and markets proprietary vaccine-based prophylactics and therapeutics, announced financial results for the quarter and nine months ended September 30, 2008. Nine Months Ended September 30, 2008 Revenue in the first nine months of 2008 increased 24.7% year over year to $22.7 million from $18.2 million, while gross profit increased 17.2% to $16.8 million from $14.3 million during the same time period last year. Operating expenses increased 146.9% year over year to $4.3 million from $1.8 million for the...
Source: Vaccine Weekly (2008-12-03)
|
